LY3537031 + Placebo
Phase 1Active 0 watching 0 views this week💤 Quiet
33
Development Stage
✓
Pre-clinical2
Phase 13
Phase 24
Phase 35
ApprovedIndication / Disease
Overweight
Conditions
Overweight, Obesity
Trial Timeline
Sep 5, 2024 → Jul 1, 2026
NCT ID
NCT06606106About LY3537031 + Placebo
LY3537031 + Placebo is a phase 1 stage product being developed by Eli Lilly for Overweight. The current trial status is active. This product is registered under clinical trial identifier NCT06606106. Target conditions include Overweight, Obesity.
Hype Score Breakdown
Clinical
10
Activity
5
Company
10
Novelty
3
Community
2
Clinical Trials (4)
| NCT ID | Phase | Status |
|---|---|---|
| NCT07219953 | Phase 3 | Recruiting |
| NCT07219966 | Phase 3 | Recruiting |
| NCT06606106 | Phase 1 | Active |
| NCT04648865 | Phase 1 | Completed |
Competing Products
20 competing products in Overweight